← Leaderboards
Marlena Habal
Columbia University Health Sciences
$5,428,816
Attributed
$5,428,816
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,428,816 · 2
By mechanism
U01$5,158,955 · 1
R34$269,861 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Kazuhiko Yamada$21,077,647
- Leonard Chess$400,334
- Megan Sykes$56,546,810
- Edward V Nunes$88,947,598
- Andrea B Troxel$185,878,739
Others in their field
Other Emerging Leaders on “Helper-Inducer T-Lymphocyte”
- Norbert Pardi · University Of Pennsylvania$10,034,305
- Murugaiyan Gopal · Brigham And Women'S Hospital$5,237,730
- Peter The Sage · Brigham And Women'S Hospital$4,437,393
- Michela Locci · University Of Pennsylvania$4,323,652
- Todd Christopher Bradley · Children'S Mercy Hosp (Kansas City, Mo)$4,286,880
- Duygu Ucar · Jackson Laboratory$3,828,781
Research focus
Helper-Inducer T-LymphocyteKidney TransplantationFda ApprovedHeart TransplantationImmune ResponseKidneyAntibodiesClinical TrialsChronic Kidney FailureHeart AllograftDiabetes MellitusHuman Herpesvirus 4DesignImmunosuppressionBiological MarkersBiopsyAcuteCell Free DnaCalcineurin InhibitorCessation Of LifeCd28 GeneCd80 GeneCd86 GeneMediating
Grant awards (4)
Safety and efficacy of Belatacept in heart transplantation$1,710,716
U01 · FY2025 · AI · contact PI
Safety and efficacy of Belatacept in heart transplantation$1,672,806
U01 · FY2024 · AI · contact PI
Safety and efficacy of Belatacept in heart transplantation$1,775,433
U01 · FY2023 · AI · contact PI
Belatacept in De Novo Heart Transplant$269,861
R34 · FY2020 · AI · contact PI